nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—Influenza-like symptoms—Octreotide—thymus cancer	0.0286	0.0295	CcSEcCtD
Eprosartan—Neuritis—Octreotide—thymus cancer	0.0274	0.0282	CcSEcCtD
Eprosartan—Otitis media—Octreotide—thymus cancer	0.0262	0.0271	CcSEcCtD
Eprosartan—Nephrolithiasis—Octreotide—thymus cancer	0.0254	0.0262	CcSEcCtD
Eprosartan—Viral infection—Octreotide—thymus cancer	0.0226	0.0233	CcSEcCtD
Eprosartan—Arthropathy—Octreotide—thymus cancer	0.0225	0.0232	CcSEcCtD
Eprosartan—Herpes simplex—Octreotide—thymus cancer	0.0222	0.0229	CcSEcCtD
Eprosartan—Cystitis noninfective—Octreotide—thymus cancer	0.0199	0.0206	CcSEcCtD
Eprosartan—Influenza like illness—Octreotide—thymus cancer	0.0198	0.0205	CcSEcCtD
Eprosartan—Cystitis—Octreotide—thymus cancer	0.0197	0.0204	CcSEcCtD
Eprosartan—Cramps of lower extremities—Octreotide—thymus cancer	0.0188	0.0194	CcSEcCtD
Eprosartan—Bladder pain—Octreotide—thymus cancer	0.0185	0.0191	CcSEcCtD
Eprosartan—Urine output increased—Octreotide—thymus cancer	0.0185	0.0191	CcSEcCtD
Eprosartan—Diabetes mellitus—Octreotide—thymus cancer	0.017	0.0176	CcSEcCtD
Eprosartan—Polyuria—Octreotide—thymus cancer	0.0169	0.0174	CcSEcCtD
Eprosartan—Gastroenteritis—Octreotide—thymus cancer	0.0167	0.0173	CcSEcCtD
Eprosartan—Hot flush—Octreotide—thymus cancer	0.0158	0.0164	CcSEcCtD
Eprosartan—Menopausal symptoms—Octreotide—thymus cancer	0.0157	0.0162	CcSEcCtD
Eprosartan—Arthritis—Octreotide—thymus cancer	0.0153	0.0157	CcSEcCtD
Eprosartan—Osteoarthritis—Octreotide—thymus cancer	0.0148	0.0153	CcSEcCtD
Eprosartan—Gastritis—Octreotide—thymus cancer	0.0131	0.0135	CcSEcCtD
Eprosartan—Muscular weakness—Octreotide—thymus cancer	0.0131	0.0135	CcSEcCtD
Eprosartan—Asthma—Octreotide—thymus cancer	0.0128	0.0132	CcSEcCtD
Eprosartan—Sweating increased—Octreotide—thymus cancer	0.0125	0.0129	CcSEcCtD
Eprosartan—Bronchitis—Octreotide—thymus cancer	0.0123	0.0127	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Octreotide—thymus cancer	0.0119	0.0123	CcSEcCtD
Eprosartan—Pollakiuria—Octreotide—thymus cancer	0.0118	0.0122	CcSEcCtD
Eprosartan—Hyperglycaemia—Octreotide—thymus cancer	0.0116	0.0119	CcSEcCtD
Eprosartan—Depression—Octreotide—thymus cancer	0.0114	0.0118	CcSEcCtD
Eprosartan—Neuropathy peripheral—Octreotide—thymus cancer	0.0112	0.0116	CcSEcCtD
Eprosartan—Conjunctivitis—Octreotide—thymus cancer	0.0111	0.0115	CcSEcCtD
Eprosartan—Urinary tract infection—Octreotide—thymus cancer	0.0111	0.0115	CcSEcCtD
Eprosartan—Haematuria—Octreotide—thymus cancer	0.0109	0.0112	CcSEcCtD
Eprosartan—Epistaxis—Octreotide—thymus cancer	0.0108	0.0111	CcSEcCtD
Eprosartan—Sinusitis—Octreotide—thymus cancer	0.0107	0.0111	CcSEcCtD
Eprosartan—Bradycardia—Octreotide—thymus cancer	0.0104	0.0108	CcSEcCtD
Eprosartan—Rhinitis—Octreotide—thymus cancer	0.0103	0.0106	CcSEcCtD
Eprosartan—Pharyngitis—Octreotide—thymus cancer	0.0102	0.0105	CcSEcCtD
Eprosartan—Oedema peripheral—Octreotide—thymus cancer	0.0101	0.0104	CcSEcCtD
Eprosartan—Visual impairment—Octreotide—thymus cancer	0.00988	0.0102	CcSEcCtD
Eprosartan—Tinnitus—Octreotide—thymus cancer	0.00956	0.00987	CcSEcCtD
Eprosartan—Flatulence—Octreotide—thymus cancer	0.0088	0.00908	CcSEcCtD
Eprosartan—Tension—Octreotide—thymus cancer	0.00876	0.00904	CcSEcCtD
Eprosartan—Nervousness—Octreotide—thymus cancer	0.00867	0.00895	CcSEcCtD
Eprosartan—Back pain—Octreotide—thymus cancer	0.00863	0.00891	CcSEcCtD
Eprosartan—Muscle spasms—Octreotide—thymus cancer	0.00858	0.00886	CcSEcCtD
Eprosartan—Tremor—Octreotide—thymus cancer	0.00836	0.00863	CcSEcCtD
Eprosartan—Ill-defined disorder—Octreotide—thymus cancer	0.00828	0.00855	CcSEcCtD
Eprosartan—Malaise—Octreotide—thymus cancer	0.00805	0.00831	CcSEcCtD
Eprosartan—Vertigo—Octreotide—thymus cancer	0.00802	0.00828	CcSEcCtD
Eprosartan—Syncope—Octreotide—thymus cancer	0.00801	0.00826	CcSEcCtD
Eprosartan—Palpitations—Octreotide—thymus cancer	0.00789	0.00814	CcSEcCtD
Eprosartan—Loss of consciousness—Octreotide—thymus cancer	0.00785	0.0081	CcSEcCtD
Eprosartan—Cough—Octreotide—thymus cancer	0.00779	0.00804	CcSEcCtD
Eprosartan—Arthralgia—Octreotide—thymus cancer	0.0076	0.00784	CcSEcCtD
Eprosartan—Chest pain—Octreotide—thymus cancer	0.0076	0.00784	CcSEcCtD
Eprosartan—Myalgia—Octreotide—thymus cancer	0.0076	0.00784	CcSEcCtD
Eprosartan—Anxiety—Octreotide—thymus cancer	0.00757	0.00782	CcSEcCtD
Eprosartan—Discomfort—Octreotide—thymus cancer	0.00751	0.00775	CcSEcCtD
Eprosartan—Dry mouth—Octreotide—thymus cancer	0.00743	0.00767	CcSEcCtD
Eprosartan—Shock—Octreotide—thymus cancer	0.00717	0.0074	CcSEcCtD
Eprosartan—Thrombocytopenia—Octreotide—thymus cancer	0.00713	0.00736	CcSEcCtD
Eprosartan—Tachycardia—Octreotide—thymus cancer	0.00711	0.00734	CcSEcCtD
Eprosartan—Hyperhidrosis—Octreotide—thymus cancer	0.00704	0.00727	CcSEcCtD
Eprosartan—Anorexia—Octreotide—thymus cancer	0.00694	0.00717	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00664	0.00685	CcSEcCtD
Eprosartan—Insomnia—Octreotide—thymus cancer	0.00659	0.0068	CcSEcCtD
Eprosartan—Paraesthesia—Octreotide—thymus cancer	0.00654	0.00675	CcSEcCtD
Eprosartan—Dyspnoea—Octreotide—thymus cancer	0.0065	0.0067	CcSEcCtD
Eprosartan—Somnolence—Octreotide—thymus cancer	0.00648	0.00669	CcSEcCtD
Eprosartan—Dyspepsia—Octreotide—thymus cancer	0.00641	0.00662	CcSEcCtD
Eprosartan—Decreased appetite—Octreotide—thymus cancer	0.00633	0.00654	CcSEcCtD
Eprosartan—Fatigue—Octreotide—thymus cancer	0.00628	0.00648	CcSEcCtD
Eprosartan—Constipation—Octreotide—thymus cancer	0.00623	0.00643	CcSEcCtD
Eprosartan—Pain—Octreotide—thymus cancer	0.00623	0.00643	CcSEcCtD
Eprosartan—Feeling abnormal—Octreotide—thymus cancer	0.006	0.0062	CcSEcCtD
Eprosartan—Gastrointestinal pain—Octreotide—thymus cancer	0.00596	0.00615	CcSEcCtD
Eprosartan—Urticaria—Octreotide—thymus cancer	0.00579	0.00597	CcSEcCtD
Eprosartan—Abdominal pain—Octreotide—thymus cancer	0.00576	0.00594	CcSEcCtD
Eprosartan—Body temperature increased—Octreotide—thymus cancer	0.00576	0.00594	CcSEcCtD
Eprosartan—Hypersensitivity—Octreotide—thymus cancer	0.00537	0.00554	CcSEcCtD
Eprosartan—AGTR1—neck—thymus cancer	0.00534	0.171	CbGeAlD
Eprosartan—Asthenia—Octreotide—thymus cancer	0.00523	0.0054	CcSEcCtD
Eprosartan—Pruritus—Octreotide—thymus cancer	0.00515	0.00532	CcSEcCtD
Eprosartan—Diarrhoea—Octreotide—thymus cancer	0.00498	0.00515	CcSEcCtD
Eprosartan—Dizziness—Octreotide—thymus cancer	0.00482	0.00497	CcSEcCtD
Eprosartan—Vomiting—Octreotide—thymus cancer	0.00463	0.00478	CcSEcCtD
Eprosartan—Rash—Octreotide—thymus cancer	0.00459	0.00474	CcSEcCtD
Eprosartan—Dermatitis—Octreotide—thymus cancer	0.00459	0.00474	CcSEcCtD
Eprosartan—Headache—Octreotide—thymus cancer	0.00456	0.00471	CcSEcCtD
Eprosartan—Nausea—Octreotide—thymus cancer	0.00433	0.00447	CcSEcCtD
Eprosartan—AGTR1—hematopoietic system—thymus cancer	0.00398	0.127	CbGeAlD
Eprosartan—AGTR1—epithelium—thymus cancer	0.00364	0.116	CbGeAlD
Eprosartan—AGTR1—cardiac atrium—thymus cancer	0.00302	0.0967	CbGeAlD
Eprosartan—AGTR1—pituitary gland—thymus cancer	0.00295	0.0945	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—thymus cancer	0.0028	0.0897	CbGeAlD
Eprosartan—AGTR1—thyroid gland—thymus cancer	0.00254	0.0815	CbGeAlD
Eprosartan—AGTR1—lung—thymus cancer	0.00231	0.074	CbGeAlD
Eprosartan—CYP2C9—hematopoietic system—thymus cancer	0.00192	0.0613	CbGeAlD
Eprosartan—AGTR1—lymph node—thymus cancer	0.00158	0.0506	CbGeAlD
Eprosartan—ABCC2—lymph node—thymus cancer	0.00114	0.0366	CbGeAlD
